Home » Topics » Regulatory » Patents

Patents
RSS

Antiobesity proteins described by Lilly

Oct. 25, 1996

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

MAb 1DT3-D disclosed for treatment of B-cell lymphoma

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...